Lupin receives tentative approval from USFDA for Dolutegravir and Rilpivirine Tablets
Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of US $666 million in the US (IQVIA MAT September 2022)
Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of US $666 million in the US (IQVIA MAT September 2022)
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
It offers quick relief in various types of Coughs, Colds and Sore Throat,
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Subscribe To Our Newsletter & Stay Updated